Radiological diagnostics and follow-up of rectal carcinoma;Radiologische diagnostik des rektumkarzinoms: Nachsorge und rezidivdiagnostik

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 178, Issue 10, 2006, Pages 970-978

  Vogl, Thomas J ^a   Pegios, W ^a   Bechstein, W O ^a   Floeter, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

CT; Immunoscintigraphy; MR imaging; PET; PET CT; Rectum

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; HUMAN; IMMUNOSCINTIGRAPHY; META ANALYSIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM CARCINOMA; RECURRENT CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUMOR BIOPSY;

DIAGNOSTIC IMAGING; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES; PROGNOSIS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33751046034     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926937     Document Type: Review

References (38)

1. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1996; 83: 293-304
2. Adam IJ, Mohamdee MO, Martin IG et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: 707-711
3. Quirke P, Durdey P, Dixon MF et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-999
4. Stockholm Colorectal Cancer Study Group. Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 1996; 3: 423-430
5. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646
6. Park YA, Lee KY, Kim NK et al. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 2006; 13: 645-650
7. Chen CC, Yang SH, Lin JK et al. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res 2005; 124: 169-174
8. Böhm B, Helfritzsch H, Thiele M et al. Therapieergebnisse des lokoregionären Rezidivs beim Rektumkarzinom. Zentralbl Chir 2001; 126: 596-601
9. Shoup M, Guillem JG, Alektiar KM et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002; 45: 585-592
10. Kuntz C, Glaser F, Lehnert T et al. Endosonographische Diagnostik bei präoperativer Radiotherapie des lokal fortgeschrittenen Rectumcarcinoms. Chirurg 1997; 68: 57-62
11. Lehnert T, Golling M, Buchholz J. Lokoregionäres Rezidiv des Rektumkarzinoms. Chirurg 2004; 75: 38-44
12. Ommer A, Pitt C, Krause R et al. Die transrektale ultraschallassistierte Stanzbiopsie in der Diagnostik des präsakralen Rektumkarzinomrezidivs. Zentralbl Chir 2004; 129: 58-62
13. Bipat S, Glas AS, Slors FJ et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 2004; 232: 773-783
14. Tio TL, Coene PP, van Delden OM et al. Colorectal carcinoma: preoperative TNM classification with endosonography. Radiology 1991; 179: 165-170
15. Pegios W, Hunerbein M, Schroder R et al. Vergleich zwischen endorektaler MRT (EMRT) und endorektaler Sonographie (ES) postoperativ bzw. posttherapeutisch bei rektalen Tumoren zum Ausschluss von Rezidivbzw. Residualtumoren. Fortschr Röntgenstr 2002; 174: 731-737
16. Maier AG, Barton PP, Neuhold NR et al. Peritumoral tissue reaction at transrectal US as a possible cause of overstaging in rectal cancer: histopathologic correlation. Radiology 1997; 203: 785-789
17. Rotondano G, Esposito P, Pellecchia L et al. Early detection of locally recurrent rectal cancer by endosonography. Br J Radiol 1997; 70: 567-571
18. Botterill ID, Blunt DM, Quirke P et al. Evaluation of the role of pre-operative magnetic resonance imaging in the management of rectal cancer. Colorectal Dis 2001; 3: 295-303
19. Dicle O, Obuz F, Cakmakci H. Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 1999; 72: 1155-1159
20. Torricelli P, Pecchi A, Luppi C et al. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging 2003; 28: 19-27
21. Balzer JO, Luboldt W, Vogl TJ. Wertigkeit der CT und MRT bei der Rezidivdiagnostik des kolorektalen Karzinoms. Radiologe 2003; 43: 122-127
22. Koh DM, Brown G, Temple L et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings - initial observations. Radiology 2004; 231: 91-99
23. Stückle CA, Maleszka A, Kosta P et al. Computertomographische Beurteilung von Lokalrezidiven beim operierten und nachbestrahlten Rektumkarzinom: Regelhafte und pathologische Veränderungen nach Operation und Bestrahlung des Rektumkarzinoms in 956 CT-Untersuchungen. Radiologe 2001; 41: 491-496
24. Filippone A, Ambrosini R, Fuschi M et al. Preoperative T and N staging of colorectal cancer: accuracy of contrast-enhanced multi-detector row CT colonography - initial experience. Radiology 2004; 231: 83-90
25. Tanaka J, Tsukuda S, Yuasa M et al. Usefulness of early-phase helical CT for detecting recurrent rectal cancer. Radiat Med 2003; 21: 103-107
26. Stückle CA, Koenig M, Haegele KF et al. Die Kontrastmittelkinetik im Mehrzeilen-Spiral-CT kann das Rektumkarzinomrezidiv nicht sicher delektieren. Fortschr Röntgenstr 2005; 177: 893-899
27. Abdel-Nabi H, Doerr RJ, Lamonica DM et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998; 206: 755-760
28. Lai DT, Fulham M, Stephen MS et al. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996; 131: 703-707
29. Kernstine KH, Grannis FW Jr, Rotter AJ. Is there a role for PET in the evaluation of subcentimeter pulmonary nodules? I Semin Thorac Cardiovasc Surg 2005; 17: 110-114
30. Frohlich A, Diederichs CG, Staib L et al. Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 1999; 40: 250-255
31. Crippa F, Leutner M, Belli F et al. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med 2000; 41: 1491-1494
32. Strunk H, Bucerius J, Jaeger U et al. PET-CT in der Nachsorge des kolorektalen Karzinoms: Einfluss der Bildfusion auf die Staginggenauigkeit. Fortschr Röntgenstr 2005; 177: 1235-1241
33. Libutti SK, Alexander HR Jr, Choyke P et al. A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99 mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. Ann Surg Oncol 2001; 8: 779-786
34. Fuster D, Maurel J, Muxi A et al. Is there a role for (99 m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? Q J Nucl Med 2003; 47: 109-115
35. Willkomm P, Bender H, Bangard M et al. FDG PET and immunoscintigraphy with 99 mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 2000; 41: 1657-1663
36. Van Cutsem EJ, Kataja W. ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Ann Oncol 2005; 16 Suppl. 1: i18-19
37. Kornek GV, Scheithauer W. Nachsorge des kolorektalen Karzinoms. Onkologie 2003; 26: 303-307
38. Eu KW, Seow-Choen F, Ho JM et al. Local recurrence following rectal resection for cancer. J R Coll Surg Edinb 1998; 43: 393-396